Conversely, hepatocytes with Nlrp3-deficiency and/or pharmacological inhibition of Nlrp3 ameliorate liver inflammation by reducing IL-1β, IL-6, and TNF-α production; they also ameliorate liver fibrosis by reducing Col1a and aSma. Here, IL1B is linked to Hepatitis.